1. Home
  2. DFNS vs CCEL Comparison

DFNS vs CCEL Comparison

Compare DFNS & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DFNS

T3 Defense Inc. Common Stock

N/A

Current Price

$0.51

Market Cap

27.2M

ML Signal

N/A

Logo Cryo-Cell International Inc.

CCEL

Cryo-Cell International Inc.

N/A

Current Price

$3.53

Market Cap

29.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DFNS
CCEL
Founded
2013
1989
Country
United States
United States
Employees
15
N/A
Industry
Professional Services
Managed Health Care
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.2M
29.6M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
DFNS
CCEL
Price
$0.51
$3.53
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
2.3M
9.6K
Earning Date
04-09-2026
04-14-2026
Dividend Yield
N/A
3.84%
EPS Growth
N/A
N/A
EPS
N/A
0.01
Revenue
N/A
$25,384,279.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$390.96
Revenue Growth
N/A
9.76
52 Week Low
$0.42
$2.72
52 Week High
$2.68
$5.76

Technical Indicators

Market Signals
Indicator
DFNS
CCEL
Relative Strength Index (RSI) 31.41 49.99
Support Level $0.44 $3.18
Resistance Level $0.88 $3.57
Average True Range (ATR) 0.10 0.30
MACD 0.03 -0.00
Stochastic Oscillator 14.13 22.73

Price Performance

Historical Comparison
DFNS
CCEL

About DFNS T3 Defense Inc. Common Stock

T3 Defense Inc is a holding company that acquires and operates mission-critical defense businesses involved in national security programs. It focuses on manufacturers with tough customer relationships and solid order backlogs, often capacity-and resource-constrained and specialized areas such as drones and autonomous vehicles, counter-drone systems, main manufacturing, tactical robotics, and AI software and system integration. Through disciplined acquisitions, centralized capital and ideas, and decentralized day-to-day operations, it aims to strengthen essential defense capabilities and build long-term value.

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

Share on Social Networks: